Aims/hypothesis Few studies examine the association between age at diagnosis and
subsequent complications from type 2 diabetes. This paper aims to summarise the risk of …

Diabetic macular edema (DME) can cause blindness in diabetic patients suffering from
diabetic retinopathy (DR). DM parameters controls (glycemia, arterial tension, and lipids) are …

Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population.
The diabetes Control and Complications Trial reported that 27% of patients affected by type …

Diabetic macular edema (DME) is the leading cause of blindness in young adults in
developed countries, affecting 12% of type 1 and 28% of type 2 diabetic patients. The gold …

Purpose: To determine the prevalence of microangiopathy, and its risk factors in a
population-based study of diabetes mellitus patients in the north-eastern area of Spain …

PURPOSE: To determine the incidence of diabetic retinopathy (DR) progression after
phacoemulsification in patients with type II diabetes. SETTING: Service of Ophthalmology …

Background/aims To determine the incidence of any diabetic retinopathy (any-DR), sight-
threatening diabetic retinopathy (STDR) and diabetic macular oedema (DMO) and their risk …

Diabetic retinopathy is one of the most common comorbidities of diabetes. Unfortunately, the
recommended annual screening of the eye fundus of diabetic patients is too resource …

Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population,
and its prevalence is variable. The Diabetes Control and Complications Trial (DCCT) …

Diabetes mellitus is a group of metabolic disorders of carbohydrate metabolism in which
glucose is underutilized, producing hyperglycemia. The latter complications of diabetes …